Form D · Hedge Fund

Lenrock Healthcare Total Return Fund I L P

New York, NY · CIK 0001379153

Offering snapshot reported Mar 9, 2010 · SEC filing

Reported sold: $2.35M
Investors reported: 6
Minimum accepted: $1M
First sale: Aug 14, 2006

Fundraising history

Reported sold

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
Mar 9, 2010	Amendment	$2,350,000	$0vs Mar 9, 2009	6	SEC filing
Mar 9, 2009	Amendment	$2,350,000	No comparison	Not reported	SEC filing
Oct 16, 2006	Paper	Not reported	No comparison	Not reported	SEC filing

Offering details

Securities: Not reported
Exemptions: 06, 3C, 3C.7
Duration over one year: Yes
Business combination: No

Sales commissions: $4K
Finders' fees: $0
Form D file number: 021-95835

Sales compensation recipients

Scroll to see all columns →

Recipient	CRD	Associated broker-dealer
The Griswold Company	32944

Source: Form D, filed Mar 9, 2010. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
Howard G Capek	Executive
David Di Tommaso	Executive
Joseph D France	Executive
Lawrence J Griffin	Executive
N/A Lenrock Capital, Llc	Promoter
N/A Lenrock Management Group, Lp	Executive
Michael E Stupay	Executive
Joseph D Tagliente	Executive

Issuer details

Industry: Pooled Investment Fund (See others in industry)

Address:

C/O Lenrock Capital, Llc 111 Broadway, Suite 1002
New York, NY, 10006